Skip to main content
. 2016 Aug 29;7(42):67748–67759. doi: 10.18632/oncotarget.11682

Figure 1. Serum HE4 is strongly associated with progression of CKD in patients.

Figure 1

A. Differential levels of serum HE4 in patients with CKD or NC (normal healthy control) group. Results indicated that serum HE4 levels were elevated in patients with CKD, and increased with a higher stage of CKD (*P < 0.0001). B. Differential levels of serum HE4 for male patients. Serum HE4 levels are elevated in male patients with CKD (*P < 0.0001). C. Differential levels of serum HE4 for female patients. Serum HE4 levels are elevated in female patients with CKD (*P < 0.0001). D. Receiver-operating characteristic curve analysis displaying the diagnostic power in predicting disease severity of CKD in patients by serum HE4 levels (area under the curve, AUC: 0.981).